[Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats]

Yao Xue Xue Bao. 2004 Jan;39(1):1-4.
[Article in Chinese]

Abstract

Aim: To determine the protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats.

Methods: Slow microinjection of endothelin-1 (120 pmol in 6 microL, for > 6 min) into the region near the middle cerebral artery was used to induce focal cerebral ischemia. ONO-1078 (0.1 mg.kg-1) was i.p. injected 1 h before endothelin-1 injection. Neurological symptoms, brain edema, brain infarction size, and the survival neurons in cortex and striatum were observed 24 h after ischemia.

Results: Intracerebral microinjection of endothelin-1 induced remarkable neurological symptoms, brain infarction, brain edema, and decrease of survival neurons in the cortex and striatum. In rats pretreated with ONO-1078, endothelin-1-induced brain edema and brain infarction size were decreased. The numbers of survival neurons in striatum and cortex were increased significantly. The neurological symptoms were improved but not significantly.

Conclusion: ONO-1078 possesses neuroprotective effect against cerebral ischemic injury induced by endothelin-1, therefore, leukotrienes may play a role in the injury of cerebral ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Brain Edema / pathology
  • Brain Ischemia / chemically induced
  • Brain Ischemia / pathology*
  • Cerebral Cortex / pathology
  • Cerebral Infarction / pathology
  • Chromones / pharmacology*
  • Corpus Striatum / pathology
  • Endothelin-1
  • Leukotriene Antagonists / pharmacology*
  • Male
  • Neurons / drug effects
  • Neuroprotective Agents / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Chromones
  • Endothelin-1
  • Leukotriene Antagonists
  • Neuroprotective Agents
  • pranlukast